Cardiothoracic Surgery

Our services and vision:

The Department of Cardiothoracic Surgery provides treatment for congenital and acquired conditions of the heart and chest, in patients of all ages. Each year we are performing more than 600 adult cardiac surgeries, 700 thoracic surgeries and 200 pediatric cardiac surgeries. In collaboration with the HKWC, the department has developed state-of-the-art operating and hybrid suites, robotic, and minimally invasive facilities.

The adult cardiac surgery has well-established clinical programs in areas of myocardial revascularization, heart valve surgery, major aortic surgery, transplantation and circulatory support devices. Besides improving results in highly complex cardiac operations, advance minimally invasive approaches now being routinely performed. These includes robotic and endoscopic assisted surgery, endovascular aortic repair (TEVAR) and transcatheter aortic valve implantation (TAVI). New technologies such as Neochord for mitral repair and J-valve for replacing leaking aortic valve are now available.

General thoracic surgery covers benign and malignant diseases of the lung, chest wall, airway, mediastinum and diaphragm. Most of the surgery is performed using video-assisted thoracic surgery (VATS).

Besides heart and lung transplantation for end-stage diseases, mechanical assist device procedures are now routinely done. Heart transplant and ventricular assist programs at QMH have grown over the last decade, while maintaining excellent outcomes.

Apart from all range of open and close heart surgeries for children with congenital and acquired heart conditions, the department provides mechanical cardiac support, such as extracorporeal membrane oxygenation (ECMO), external and implantable ventricular assist device (VAD) to young children in need.

Currently we are the main referral center for complex cardiac conditions, the only center for heart or lung failure surgery and pediatric heart surgery.

In addition to patient care, it also provides education and training to cardiothoracic surgical residents and fellows. Its commitment to transparency and public accountability is upheld with the regular publication of the biennial report detailing the outcomes, which is available to public.

Notable milestones in the evolution:

Year Event
1957
  • Introduced Thoracic Surgery
1968
  • An Open Heart Unit was established
  • First successful open heart operation performed in Grantham Hospital
1991
  • The Tuberculosis, Chest and Heart Diseases Association vested the management and control of the Hospital under Hospital Authority
1992
  • First heart transplant in Hong Kong
1995
  • First single-lung transplant in Hong Kong
  • First heart-Iung transplant in Hong Kong
  • Introduced transmyocardial laser revascularization
1996
  • Introduced off pump CABG and minimally invasive direct coronary artery bypass (MIDCAB)
1997
  • First double-lung transplant in Hong Kong
1998
  • Outcome management for adult cardiac patients to improve unsatisfactory outcomes
1999
  • Outcome management for coronary artery bypass grafting (CABG) successfully implemented
  • Introduced nitric oxide for treating congenital heart disease with pulmonary hypertension
  • Carried out the tracheoplasty for congenital tracheal stenosis
2000
  • Carried out the ECMO operation for paediatric patient
  • Introduced Radio Frequency Ablation (RFA) for Atrial Fibrillation (AF)
  • Introduced risk stratification audit project in adult heart surgery
2001
  • Introduced the first para corporeal LVAD in children in Hong Kong
2004
  • Introduced Endoscopic Vein Harvesting(EVH) in CABG patients
2006
  • First minimally invasive mitral valve repair operation
2008
  • Relocated successfully from Grantham Hospital to Queen Mary Hospital
2009
  • First Paediatric heart transplantation in Hong Kong
2010
  • First V-A ECMO in Paediatric case
  • First Heart-liver transplantation in Hong Kong
  • First implantable Left Ventricular Artificial Devices (LVAD) in Hong Kong
  • First V-V ECMO in adult case (lung transplant case)
  • New outcome management for Coronary Artery Bypass Grafting (CABG) successfully implemented
2011
  • 1st ventricular assist device (CentriMag) implantation in supporting right and left heart for patient with acute ventricular failure
2012
  • “Nurse Led Programme in Building Trust and Partnership in the Management of Care with LVAD Patients” won the Asian Hospital Management Awards (Bio medical Equipment / Facilities Improvement Project)
  • Introduced the first transfemoral TAVI operation
  • Published the first “QMH Cardiac Surgery Biennial Report 2010-2011”
2013
  • Introduced the first transapical TAVI operation
  • First LVAD patient received heart transplant
  • First Paediatric patient with Berlin Heart and later received heart transplant
2014
  • First robotic-assisted mitral valve repair operation
  • First Paediatric CABG and CentriMag LVAD implantation
  • Hong Kong West Cluster & Queen Mary Hospital Outstanding Teams Award 2014
    - Left Ventricular Assist Devices (LVAD) Nursing Team
2016
  • Held the first Hong Kong End Stage Heart Failure Management symposium
2017
  • World longest BiVAD (CentriMag) support (282 days) successfully bridged to heart transplant
2018
  • First NeoChord mitral valve repair operation in Asia
  • Held the first Hong Kong Valve symposium
  • Held the third Hong Kong End Stage Heart Failure Management symposium
2019
  • Hong Kong West Cluster & Queen Mary Hospital Outstanding Teams Award 2019
    - Paediatric extracorporeal membrane oxygenation (ECMO) Team